Catalog Number JHJR050502J |
Device Problem
Detachment of Device or Device Component (2907)
|
Patient Problem
No Known Impact Or Consequence To Patient (2692)
|
Event Date 12/13/2019 |
Event Type
malfunction
|
Event Description
|
The following was reported to gore: on (b)(6) 2019, the patient underwent treatment for a significantly calcified occlusion lesion in the left superficial femoral artery using two gore® viabahn® endoprosthesis with heparin bioactive surface (viabahn) from the superficial femoral artery (sfa) to below knee (bk) bypass procedure.A 6mm x 5cm viabahn was placed first followed by a 5mm x 5cm viabahn.Upon removal of the 5mm x 5cm viabahn delivery catheter, strong resistance was encountered.However, the delivery catheter was removed from the patient.Then a smart stent was placed within the two viabahns.After the treatment of the occlusion lesion in the left sfa, the sfa-bk bypass procedure was performed.During the bypass procedure, it was observed that a separated tip/portion of the delivery catheter remained in the left sfa.The length of the separated tip was about 5cm.The tip was immediately retracted from the patient.The bypass procedure was completed without further issue.The patient tolerated the procedure.It was reported that pre-ballooning was not performed.Reportedly, the tip of the delivery catheter may have been caught on the sheath tip or caught within the significantly calcified occlusion lesion and may have become separated during removal of the delivery catheter.It was stated that the second device was identified as the device with the delivery catheter tip separation.
|
|
Manufacturer Narrative
|
Results code 1: 213: a review of the manufacturing records for the device verified the lot met pre-release specifications.Results code 2: 213: the engineering evaluation stated the following: the distal shaft, upon which the endoprosthesis was mounted, and the distal tip was returned.Approximately 5 cm of the distal shaft was returned with a kink approximately 2 cm from the transition end of the distal shaft.The stainless steel braid in the distal shaft on the transition end appeared to be frayed and broken.Based on the device examination performed, no manufacturing anomalies were identified to which the event could be definitively attributed.
|
|
Manufacturer Narrative
|
Additional manufacturing narrative: c1.Name (#1) - cbas® heparin surface; manufacturer/compounder: w.L.Gore & associates, inc.Lot #20746523.Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
|
|
Manufacturer Narrative
|
Additional manufacturer narrative: a1.- patient identifier.
|
|
Search Alerts/Recalls
|